IO Biotech’s (IOBT) Buy Rating Reiterated at HC Wainwright
IO Biotech (NASDAQ:IOBT – Get Free Report)‘s stock had its “buy” rating restated by analysts at HC Wainwright in a report issued on Tuesday,Benzinga reports. They currently have a $12.00 price target on the stock. Separately, Piper Sandler upgraded IO Biotech to a “strong-buy” rating in a research report on Wednesday, March 12th. Get Our […]
IO Biotech (NASDAQ:IOBT – Get Free Report)‘s stock had its “buy” rating restated by analysts at HC Wainwright in a report issued on Tuesday,Benzinga reports. They currently have a $12.00 price target on the stock. Separately, Piper Sandler upgraded IO Biotech to a “strong-buy” rating in a research report on Wednesday, March 12th. Get Our […]
